ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Antman, Clanton begin work at NCI.

December 5, 2003

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

NCAB Approves Addition Of Two New Organ Systems

February 14, 1986

DCPC Concepts OKd Include Nurse Research Training

May 25, 1984

One Flexible Sigmoidoscopy Can Reduce Risk by 31 Percent

September 30, 2011

DCT Board Okays Recompetitions

June 21, 1985